<DOC>
	<DOC>NCT01394419</DOC>
	<brief_summary>N-acetylcysteine may prevent acute kidney injury in high risk patients undergoing off-pump coronary artery bypass graft.</brief_summary>
	<brief_title>Effect of N-acetylcysteine on Prevention of Acute Kidney Injury in High Risk Patients Undergoing Off-pump Coronary Artery Bypass Graft</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Patients undergoing offpump coronary artery bypass surgery and meets more than one of the following criteria; preoperative serum creatinine &gt; 1.4 mg/dl Age &gt; 70 years Diabetes mellitus left ventricular ejection fraction &lt; 35 % or congestive heart failure (NYHA III or IV) emergency surgery or reoperation preoperative acute renal failure, patients on dialysis, use of Nacetylcystein within 5 days of surgery, history of hypersensitivity to Nacetylcystein</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>